Skip to main navigation Skip to search Skip to main content

Running in the family? Structural brain abnormalities and iq in offspring, siblings, parents, and co-twins of patients with schizophrenia

  • S.M.C. De Zwarte
  • , R.M. Brouwer
  • , A. Tsouli
  • , W. Cahn
  • , M.H.J. Hillegers
  • , H.E. Hulshoff Pol
  • , R.S. Kahn
  • , N.E.M. Van Haren

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

© 2018 The Author(s) 2018.Structural brain abnormalities and cognitive deficits have been reported in patients with schizophrenia and to a lesser extent in their first-degree relatives (FDRs). Here we investigated whether brain abnormalities in nonpsychotic relatives differ per type of FDR and how these abnormalities are related to intelligent quotient (IQ). Nine hundred eighty individuals from 5 schizophrenia family cohorts (330 FDRs, 432 controls, 218 patients) were included. Effect sizes were calculated to compare brain measures of FDRs and patients with controls, and between each type of FDR. Analyses were repeated with a correction for IQ, having a nonpsychotic diagnosis, and intracranial volume (ICV). FDRs had significantly smaller ICV, surface area, total brain, cortical gray matter, cerebral white matter, cerebellar gray and white matter, thalamus, putamen, amygdala, and accumbens volumes as compared with controls (ds < -0.19, q < 0.05 corrected). Offspring showed the largest effect sizes relative to the other FDRs; however, none of the effects in the different relative types survived correction for multiple comparisons. After IQ correction, all effects disappeared in the FDRs after correction for multiple comparisons. The findings in FDRs were not explained by having a nonpsychotic disorder and were only partly explained by ICV. FDRs show brain abnormalities that are strongly covarying with IQ. On the basis of consistent evidence of genetic overlap between schizophrenia, IQ, and brain measures, we suggest that the brain abnormalities in FDRs are at least partly explained by genes predisposing to both schizophrenia risk and IQ.
Original languageEnglish
Pages (from-to)1209-1217
JournalSchizophrenia bulletin
Volume45
Issue number6
DOIs
Publication statusPublished - 24 Oct 2019
Externally publishedYes

Funding

This work was supported by National Alliance for Research in Schizophrenia and Affective Disorders (NARSAD) (20244 to Prof. Hillegers), The Netherlands Organisation for Health Research and Development (ZonMw) (908-02-123 to Prof. Hulshoff Pol), and Netherlands Organisation for Scientific Research (NWO-VIDI) (452-11-014 to Prof. van Haren and 917-46-370 to Prof. Hulshoff Pol). The infrastructure for the GROUP study is funded through the Geestkracht programme of the Dutch Health Research Council (ZonMw, grant number 10-000-1001), and matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag) and universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ inGeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord Holland Noord. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht, and Parnassia psycho-medical center, The Hague. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGzE, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh voor Geestelijke Gezondheid, Mondriaan, Virenze riagg, Zuyderland GGZ, MET ggz, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Utrecht: University Medical Center Utrecht and the mental health institutions Altrecht, GGZ Centraal, and Delta.)

FundersFunder number
Dutch Health Research Council10-000-1001
Erasmus Medical Centre
NWO-VIDI917-46-370
The Netherlands Organisation for Health Research and Development
Eli Lilly and Company
AstraZeneca
National Alliance for Research on Schizophrenia and Depression20244
ZonMw908-02-123
Academisch Medisch Centrum
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
GGZ InGeest
Rivierduinen
H. Lundbeck A/S

    Fingerprint

    Dive into the research topics of 'Running in the family? Structural brain abnormalities and iq in offspring, siblings, parents, and co-twins of patients with schizophrenia'. Together they form a unique fingerprint.

    Cite this